CIMAB

Company profile

CIMAB company profile

CIMAB commercializes biopharmaceutical products derived from monoclonal antibody research, with a portfolio addressing oncology, autoimmune, and infectious diseases. they manages licensing, distribution, and partnership agreements for therapeutics and diagnostics developed by affiliated research centers. They provides clinical development support, regulatory affairs services, pharmacovigilance, and market access coordination across multiple regions. The company structures technology transfer and contract manufacturing arrangements to expand supply and localized production. They oversees intellectual property management and out‑licensing programs to enable international commercialization. The company offers medical information and product documentation to healthcare stakeholders through controlled channels. They operates under compliance frameworks aligned with international standards for quality, safety, and post‑marketing surveillance.